1/16
03:05 pm
sny
Sanofi (NASDAQ:SNY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Neutral
Report
Sanofi (NASDAQ:SNY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
1/16
05:07 am
sny
Sanofi (NASDAQ:SNY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Low
Report
Sanofi (NASDAQ:SNY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
1/15
03:41 pm
sny
JPM26: Leo Pharma's growth strategy puts a spotlight on rare dermatology diseases [Yahoo! Finance]
Low
Report
JPM26: Leo Pharma's growth strategy puts a spotlight on rare dermatology diseases [Yahoo! Finance]
1/15
02:14 pm
sny
State Street's crypto push, FDA delays review of Eli Lilly GLP-1 [Yahoo! Finance Canada]
Low
Report
State Street's crypto push, FDA delays review of Eli Lilly GLP-1 [Yahoo! Finance Canada]
1/15
12:30 pm
sny
Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix [Seeking Alpha]
Low
Report
Why Sanofi May Need To Top $2.4 Billion For Ocular Therapeutix [Seeking Alpha]
1/15
09:33 am
sny
Novavax (NVAX) Is Up 7.5% After Pivot To Partner-Led Model And Sanofi Collaboration - Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
Novavax (NVAX) Is Up 7.5% After Pivot To Partner-Led Model And Sanofi Collaboration - Has The Bull Case Changed? [Yahoo! Finance]
1/15
08:31 am
sny
Does Sanofi (SNY) Have a Long Runway for Future Growth? [Yahoo! Finance]
Low
Report
Does Sanofi (SNY) Have a Long Runway for Future Growth? [Yahoo! Finance]
1/15
08:04 am
sny
Ocular surges on report of Sanofi buyout bid [Seeking Alpha]
Low
Report
Ocular surges on report of Sanofi buyout bid [Seeking Alpha]
1/15
01:13 am
sny
Press Release: Myqorzo and Redemplo approved in China [Yahoo! Finance]
Low
Report
Press Release: Myqorzo and Redemplo approved in China [Yahoo! Finance]
1/15
01:00 am
sny
Press Release: Myqorzo and Redemplo approved in China
Low
Report
Press Release: Myqorzo and Redemplo approved in China
1/14
12:36 pm
sny
JPM26: Sanofi's COAST 1 clinical trials exhibit positive results, with researchers optimistic for COAST 2 results for amlitelimab [Yahoo! Finance]
Low
Report
JPM26: Sanofi's COAST 1 clinical trials exhibit positive results, with researchers optimistic for COAST 2 results for amlitelimab [Yahoo! Finance]
1/14
11:21 am
sny
Jim Cramer Highlights Sanofi's Bid for Dynavax [Yahoo! Finance]
Low
Report
Jim Cramer Highlights Sanofi's Bid for Dynavax [Yahoo! Finance]
1/13
03:41 pm
sny
JPM26: ThermoFisher ‘very positive' on strategic M&A as deals expand capabilities [Yahoo! Finance]
Low
Report
JPM26: ThermoFisher ‘very positive' on strategic M&A as deals expand capabilities [Yahoo! Finance]
1/13
01:36 pm
sny
Thermo Fisher wins contracts as pharma shifts production to US, CEO says [Yahoo! Finance]
Low
Report
Thermo Fisher wins contracts as pharma shifts production to US, CEO says [Yahoo! Finance]
1/12
08:27 am
sny
Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Milestone Payment Under Collaboration with Sanofi [Yahoo! Finance]
Low
Report
Recludix Pharma Announces Dosing of First Subjects in a Phase 1 Study of REX-8756, a Potent and Selective Oral STAT6 Inhibitor, and Achieves Associated $20 Million Milestone Payment Under Collaboration with Sanofi [Yahoo! Finance]
1/12
04:45 am
sny
Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to ‘Equal Weight' with EUR 85 PT [Yahoo! Finance]
Medium
Report
Sanofi (SNY) Reports Regulatory Win, Barclays Downgrades to ‘Equal Weight' with EUR 85 PT [Yahoo! Finance]
1/12
01:21 am
sny
Press Release: Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes [Yahoo! Finance]
Low
Report
Press Release: Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes [Yahoo! Finance]
1/12
01:00 am
sny
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
Low
Report
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
1/10
07:02 pm
sny
How Investors Are Reacting To Sanofi (ENXTPA:SAN) Winning First-in-Class EU Nod For Wayrilz [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Sanofi (ENXTPA:SAN) Winning First-in-Class EU Nod For Wayrilz [Yahoo! Finance]
1/9
07:37 am
sny
CytoReason extends its collaboration with Sanofi to advance AI-driven drug discovery [Yahoo! Finance]
Low
Report
CytoReason extends its collaboration with Sanofi to advance AI-driven drug discovery [Yahoo! Finance]
1/8
07:21 am
sny
Flu medication is in short supply in part of U.S. as cases soar [Seeking Alpha]
Low
Report
Flu medication is in short supply in part of U.S. as cases soar [Seeking Alpha]
1/7
08:47 am
sny
Arrowhead gains approval of Redemplo in China for high triglycerides [Seeking Alpha]
Low
Report
Arrowhead gains approval of Redemplo in China for high triglycerides [Seeking Alpha]
1/7
08:10 am
sny
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/6
11:46 pm
sny
Is Sanofi (ENXTPA:SAN) Pricing Reflect Its Discounted Cash Flow Potential Today [Yahoo! Finance]
Low
Report
Is Sanofi (ENXTPA:SAN) Pricing Reflect Its Discounted Cash Flow Potential Today [Yahoo! Finance]
1/6
12:00 pm
sny
Sanofi (NASDAQ:SNY) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating.
Low
Report
Sanofi (NASDAQ:SNY) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating.